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Here, we report on the identification of a 
highly polymorphic tetranucleotide repeat 
(named DXpS) mapping to within a CpG 
island on the Xp. This island is 191 bp 
upstream from the start of the repeat 
element, and contains sites for the HhaI, 
HpaII and BstUI methyl-sensitive restriction 
enzymes (Figure 1). We developed the 
DXpS and the HUMARA markers into a 
biplex methylation-based quantitative 
fluorescent PCR assay. For DXpS we 
observed twelve alleles with negligible 
stuttering (Figure 2). DXpS exhibited a 
heterozygosity rate of 87% (n = 60), 
matching that of HUMARA. The combined 
informativeness of the biplex assay was 
98%. Random and nonrandom X-inactivation 
patterns inferred with DXpS in phenotypically 
normal females and haemophiliac females 
carrying a defective F8 gene were highly 
concordant (r2 = 0.96) with HUMARA 
patterns (Figures 3, 4 and 5).  
Figure 2. Allele distribution for the DXpS repeat locus. 
Eletropherogram of alleles observed in 60 unrelated females. 
The intensity of the red line tracing is indicative of the frequency 
of alleles. Allele names are the length in base pairs of each 
fluorescence peak. Allele span, the difference in length between 
the longest and the shortest allele per locus, is 41 bp. 
 
Machado, FB1; ,Ramos, ES1; Radic, CP3; De Brasi, CD3; Medina-Acosta, E2,4 
1Universidade de São Paulo, Brazil. 
2Universidade Estadual do Norte Fluminense Darcy Ribeiro, Brazil. 
3Academia Nacional de Medicina, Argentina. 
4Hospital Escola Álvaro Alvim, Brazil. 
filipebma@yahoo.com.br 
Identification of a highly polymorphic tetranucleotide repeat locus (DXpS) at 
Xp and development of a DXpS/HUMARA biplex methylation-based PCR 
assay that enhances detection of X-chromosome inactivation 
RESULTS 
DXpS represents a notable advancement in 
detecting X-chromosome inactivation due to 
the observed high rate of heterozygosity, 
negligible occurrence of stutters, concordance 
with HUMARA, and the apparent neutrality of 
allelic variants. 
CONCLUSION 
In silico mining of microsatellites 
 Distance of CpG island <300bp 
Concordance with the HUMARA assay 
 Presence of methylation sensitive 
restriction enzyme site 
The aim was to verify the presence of 
microsatellites tetra- and pentanucleotides 
near differentially methylated CpG islands in 
promoter regions of the human X 
chromosome, and develop a methylation-
based PCR assay that enhances detection 
of X-chromosome inactivation.  
The identification of microsatellites was 
performed in silico with bioinformatics tools, 
and criteria developed by the group 
regarding the in silico prediction of 
informativeness. We analyzed promoter 
regions of genes that do not escape the 
inactivation of chromosome X,2 containing 
CpG islands which had been validated in 
vitro 3,4. 
The methylation-based PCR assay in exon 1 
of the human androgen receptor AR gene 
(HUMARA) is the gold standard indirect 
method for determination of activation status 
of human X chromosomes. The test is based 
on differential methylation between the 
active X chromosome (unmethylated) and 
inactive (methylated) of a CpG island in 
Xq12, close to a highly polymorphic (CAG)n 
microsatellite. HUMARA assay provides 
heterozygosity rates ~85% worldwide. This 
means that in a proportion of females the 
HUMARA assay is uninformative. Allele 
designation and quantification from 
trinucleotide repeats demand normalizing for 
minor (stutter) products differing from the 
original template by multiples of the repeat 
unit. Moreover, the HUMARA genotype is not 
neutral, being linked to Kennedy´s disease 
and has been implicated in breast cancer 
risk.1  
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 Validation of differential methylation 
Validation of the polymorphism in the 
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Figure 3. Random and nonrandom X-inactivation allele ratios are 
concordant between the tetranucleotide DXpS repeat and the 
HUMARA (CAG)n loci. 
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Figure 1. Schematic representation of the region containing 
the new polymorphic marker on Xp for assaying the 
methylation state of X chromosomes. 
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Figure 4. Inactivation pattern of the HUMARA and DXpS loci in a 
woman with haemophilia A due to skewed X-chromosome 
inactivation of the normal-F8 bearing homolog (A) PCR 
amplification with biplex before HpaII digestion. (B) PCR 
amplification with biplex after HpaII digestion. The alleles are 
represented in base pairs (bp). 
Figure 5. Demonstration that the differential methylation in both 
DXpS and HUMARA markers identify the same chromosome. 
Nuclear family genotyped with the biplex assay. Mother (A) and 
father (C) before digestion with HpaII, and daughter (B) after 
digestion with HpaII. Note that the paternal chromosome is 
preferentially active.  
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